Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tarek Nafee

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Cardio-Oncology (London, England)|January 14, 2021
A virtual-hybrid approach to launching a cardio-oncology clinic during a pandemicSherry-Ann Brown, Sahishnu Patel, David Rayan, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|June 29, 2019
Characterization of Major and Clinically Relevant Non-Major Bleeds in the APEX TrialMegan K Yee, C Michael Gibson, Tarek Nafee, et al.
Research and Practice in Thrombosis and Haemostasis|February 29, 2020
Machine learning to predict venous thrombosis in acutely ill medical patientsTarek Nafee, C Michael Gibson, Ryan Travis, et al.
American Heart Journal|April 15, 2018
Symptomatic event reduction with extended-duration betrixaban in acute medically ill hospitalized patientsC Michael Gibson, Tarek Nafee, Megan K Yee, et al.
Journal of Thrombosis and Thrombolysis|December 1, 2017
Increased benefit of betrixaban among patients with a history of venous thromboembolism: a post-hoc analysis of the APEX trialMegan K Yee, Tarek Nafee, Yazan Daaboul, et al.
Current Cardiology Reports|March 15, 2019
Most Promising Therapies in Interventional CardiologyMathieu Kerneis, Tarek Nafee, Megan K Yee, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|June 29, 2019
Association of D-dimer Levels with Clinical Event Rates and the Efficacy of Betrixaban versus Enoxaparin in the APEX TrialC Michael Gibson, Lisa K Jennings, Gerald Chi, et al.
Thrombosis and Haemostasis|November 13, 2018
Asymptomatic Deep Vein Thrombosis is Associated with an Increased Risk of Death: Insights from the APEX TrialArzu Kalayci, C Michael Gibson, Gerald Chi, et al.
Circulation. Cardiovascular Interventions|February 2, 2019
Association of International Normalized Ratio Stability and Bleeding Outcomes Among Atrial Fibrillation Patients Undergoing Percutaneous Coronary InterventionMathieu Kerneis, Megan K Yee, Roxana Mehran, et al.
Circulation. Cardiovascular Interventions|November 12, 2019
Novel Oral Anticoagulant Based Versus Vitamin K Antagonist Based Double Therapy Among Stented Patients With Atrial Fibrillation: Insights From the PIONEER AF-PCI TrialMathieu Kerneis, Megan K Yee, Roxana Mehran, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Cardio-Oncology (London, England)|January 14, 2021
A virtual-hybrid approach to launching a cardio-oncology clinic during a pandemicSherry-Ann Brown, Sahishnu Patel, David Rayan, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|June 29, 2019
Characterization of Major and Clinically Relevant Non-Major Bleeds in the APEX TrialMegan K Yee, C Michael Gibson, Tarek Nafee, et al.
Research and Practice in Thrombosis and Haemostasis|February 29, 2020
Machine learning to predict venous thrombosis in acutely ill medical patientsTarek Nafee, C Michael Gibson, Ryan Travis, et al.
American Heart Journal|April 15, 2018
Symptomatic event reduction with extended-duration betrixaban in acute medically ill hospitalized patientsC Michael Gibson, Tarek Nafee, Megan K Yee, et al.
Journal of Thrombosis and Thrombolysis|December 1, 2017
Increased benefit of betrixaban among patients with a history of venous thromboembolism: a post-hoc analysis of the APEX trialMegan K Yee, Tarek Nafee, Yazan Daaboul, et al.
Current Cardiology Reports|March 15, 2019
Most Promising Therapies in Interventional CardiologyMathieu Kerneis, Tarek Nafee, Megan K Yee, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|June 29, 2019
Association of D-dimer Levels with Clinical Event Rates and the Efficacy of Betrixaban versus Enoxaparin in the APEX TrialC Michael Gibson, Lisa K Jennings, Gerald Chi, et al.
Thrombosis and Haemostasis|November 13, 2018
Asymptomatic Deep Vein Thrombosis is Associated with an Increased Risk of Death: Insights from the APEX TrialArzu Kalayci, C Michael Gibson, Gerald Chi, et al.
Circulation. Cardiovascular Interventions|February 2, 2019
Association of International Normalized Ratio Stability and Bleeding Outcomes Among Atrial Fibrillation Patients Undergoing Percutaneous Coronary InterventionMathieu Kerneis, Megan K Yee, Roxana Mehran, et al.
Circulation. Cardiovascular Interventions|November 12, 2019
Novel Oral Anticoagulant Based Versus Vitamin K Antagonist Based Double Therapy Among Stented Patients With Atrial Fibrillation: Insights From the PIONEER AF-PCI TrialMathieu Kerneis, Megan K Yee, Roxana Mehran, et al.
Pageof 3